C. Sies

发表

Urinary VMA, dopamine and the likelihood of neuroblastoma: a preferred way of reporting laboratory results?

C. Florkowski, P. George, R. Mackay, 2006, Annals of clinical biochemistry.

Quantitation of 25-hydroxyvitamin D in dried blood spots by 2D LC-MS/MS without derivatization and correlation with serum in adult and pediatric studies.

S. Berry, C. Camargo, C. Grant, 2018, Clinica chimica acta; international journal of clinical chemistry.

Evaluation of Abbott Architect high-sensitivity troponin I assay for haemolysis interference.

C. Florkowski, P. George, J. Wallace, 2015, Pathology.

Effect of atorvastatin on plasma levels of asymmetric dimethylarginine in patients with non‐ischaemic heart failure

C. Frampton, C. Florkowski, R. Scott, 2008, European journal of heart failure.

Re-emergence of thiamine deficiency disease in the Pacific islands (2014–15): A case-control study

J. Sejvar, E. Nilles, Clare Huppatz, 2018, PloS one.

A right Royal porphyria fallacy.

C. Florkowski, C. Sies, L. Pike, 2012, Clinical chemistry.

Quartz renal calculi: were we being led up the garden path?

C W Sies, J Cadwallader, C M Florkowski, 2007, Annals of clinical biochemistry.

Measurement of thiopurine methyl transferase activity guides dose-initiation and prevents toxicity from azathioprine.

R. Gearry, M. Barclay, C. Florkowski, 2005, The New Zealand medical journal.

A case of macroenzyme aspartate aminotransferase (macro-AST) in a patient with seronegative rheumatoid arthritis.

C. Florkowski, Bobby Li, C. Sies, 2022, The New Zealand medical journal.

Preanalytical stringency: what factors may confound interpretation of thiopurine S-methyl transferase enzyme activity?

M. Barclay, C. Florkowski, P. Chin, 2013, Annals of clinical biochemistry.

Dual porphyria with mutations in both the UROD and HMBS genes

C. Florkowski, J. Harraway, P. George, 2006, Annals of clinical biochemistry.

Development of a competitive binding homogeneous mobility shift assay for the quantification of adalimumab levels in patient serum.

B. Hock, J. McKenzie, Stewart M. Smith, 2019, Journal of immunological methods.

High TPMT enzyme activity does not explain drug resistance due to preferential 6‐methylmercaptopurine production in patients on thiopurine treatment

M. Barclay, P. Chin, C. Sies, 2012, Alimentary pharmacology & therapeutics.

A guide to the diagnosis of porphyria: suggested methods and case examples

C. Florkowski, C. Sies, 2006 .

Clinical indications for the investigation of porphyria: case examples and evolving laboratory approaches to its diagnosis in New Zealand.

C. Florkowski, H. Potter, P. George, 2005, The New Zealand medical journal.

Regional Variation in Analytical Techniques used in the Diagnosis and Monitoring of Porphyria: a Case for Harmonisation?

J. Gill, C. Florkowski, V. Poulos, 2015, The Clinical biochemist. Reviews.

Plasma fluorescence scanning did not detect latent variegate porphyria in nine patients with non‐p.R59W mutations

C. Florkowski, J. Davidson, P. George, 2005, Pathology.

Analytical and clinical validation of an LC-MS/MS method to measure thiopurine S-methyltransferase activity by quantifying d3-6-MMP.

C. Sies, Jing Ma, L. Pike, 2018, Clinical biochemistry.

A case of hereditary coproporphyria with posterior reversible encephalopathy and novel coproporphyrinogen oxidase gene mutation c.863T>G (p.Leu288Trp)

D. Lambie, C. Florkowski, W. Siu, 2018, Annals of clinical biochemistry.

Could these be gallstones?

J. Brooker, C. Sies, 2005, The Lancet.

Comparison of two plasma urate assays in patients receiving vitamin C supplementation

C. Frampton, C. Florkowski, L. Stamp, 2014, Pathology (Sydney).

Vitamin D status at birth and acute respiratory infection hospitalisation during infancy.

S. Morton, C. Camargo, C. Grant, 2021, Paediatric and perinatal epidemiology.

Uncertainty of sweat chloride testing: does the right hand know what the left hand is doing?

C. Florkowski, P. George, R. Mackay, 2008, Annals of clinical biochemistry.